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Abstract
Impairment of the autophagy–lysosome pathway is implicated
with the changes in a-synuclein and mitochondrial dysfunction
observed in Parkinson’s disease (PD). Damaged mitochondria
accumulate PINK1, which then recruits parkin, resulting in
ubiquitination of mitochondrial proteins. These can then be
bound by the autophagic proteins p62/SQSTM1 and LC3,
resulting in degradation of mitochondria by mitophagy. Muta-
tions in PINK1 and parkin genes are a cause of familial PD. We
found a signiﬁcant increase in the expression of p62/SQSTM1
mRNA and protein following mitophagy induction in human
neuroblastoma SH-SY5Y cells. p62 protein not only accumu-
lated on mitochondria, but was also greatly increased in the
cytosol. Increased p62/SQSMT1 expression was prevented in
PINK1 knock-down cells, suggesting increased p62 expression
was a consequence of mitophagy induction. The transcription
factors Nrf2 and TFEB, which play roles in mitochondrial and
lysosomal biogenesis, respectively, can regulate p62/SQSMT1.
We report that both Nrf2 and TFEB translocate to the nucleus
following mitophagy induction and that the increase in p62
mRNA levels was signiﬁcantly impaired in cells with Nrf2 or
TFEB knockdown. TFEB translocation also increased expres-
sion of itself and lysosomal proteins suchas glucocerebrosidase
and cathepsin D following mitophagy induction. We also report
that cells with increased TFEB protein have signiﬁcantly higher
PGC-1a mRNA levels, a regulator of mitochondrial biogenesis,
resulting in increased mitochondrial content. Our data suggests
that TFEB is activated following mitophagy to maintain
autophagy–lysosome pathway and mitochondrial biogenesis.
Therefore, strategies to increase TFEB may improve both the
clearance of a-synuclein and mitochondrial dysfunction in PD.
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The function of mitochondria and lysosomes decreases with
age (Terman et al. 2010; Nixon 2013). Age is the greatest risk
factor for developing Parkinson’s disease (PD), and the
dysfunction of mitochondria and the autophagy–lysosome
pathway (ALP) are both implicated in the pathogenesis of PD
(Schapira and Gegg 2011; Nixon 2013). The failure of
macroautophagy and chaperone-mediated autophagy, which
control the degradation of damaged mitochondria and a-
synuclein are considered particularly important in the bioen-
ergetic dysfunction and protein accumulation/aggregation
observed in PD (Narendra et al. 2008, 2010b; Alvarez-Erviti
et al. 2010; Dehay et al. 2010; Vives-Bauza et al. 2010).
Mutations in PINK1 and PARK2 (parkin) genes have been
identiﬁed as causes of autosomal recessive PD (Kitada et al.
1998; Valente et al. 2004). Loss of PINK1 or parkin function
results in mitochondrial dysfunction (Schapira and Gegg
2011). Initial work with PINK1 and parkin in Drosophila
models suggested that these proteins function in the same
signalling pathway to maintain mitochondrial function (Clark
et al. 2006; Park et al. 2006). Consequently, it has been
shown that in mammalian cells, chemical induction of
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mitophagy by use of the uncoupler carbonyl cyanide
m-chlorophenylhydrazone (CCCP) causes stabilisation of
PINK1 on the outer mitochondrial membrane. PINK1 on the
outer mitochondrial membrane in turn recruits parkin in a
kinase-dependent manner (Matsuda et al. 2010; Narendra
et al. 2010b; Vives-Bauza et al. 2010; Kondapalli et al.
2012). Parkin is an E3 ligase, which following recruitment to
depolarised mitochondria, ubiquitinates many mitochondrial
proteins. Ubiquitinated substrates include VDAC1, mito-
fusins and TOM20 (Gegg et al. 2010; Geisler et al. 2010;
Tanaka et al. 2010; Chan et al. 2011; Sarraf et al. 2013).
Ubiquitination of these substrates primes mitochondria for
recruitment to phagophores that then mature in to autophago-
somes (AP), which are double membrane vesicles in which
cargo destined for degradation are sequestered (Nixon 2013).
AP then fuse with lysosomes resulting in degradation of
dysfunctional mitochondria. Ubiquitinated mitochondrial
proteins can either bind directly to the phagophore by
binding the autophagic adaptor protein LC3-II, which is
embedded in the phagophore membrane or via p62
(SQSTM1). P62 contains a LC3 interacting domain, and
facilitates the recruitment of damaged mitochondria to the
phagophore by binding to LC3-II (Ding et al. 2010; Geisler
et al. 2010). The phosphorylation of p62 has been proposed
to initiate the binding of p62 to ubiquitinated proteins during
autophagy and mitophagy (Ichimura et al. 2013). During
mitophagy, mitochondria destined for degradation cluster
next to the nucleus (Lee et al. 2010; Narendra et al. 2010a).
The interaction between mitochondria, p62, HDAC6 and
cortactin has been implicated in mediating this perinuclear
localisation of mitochondria (Lee et al. 2010; Yan et al.
2013). Furthermore, it has been proposed that K63-linked
polyubiquitination of mitochondrial proteins by parkin
recruits p62, which then polymerises via its PB1 domain,
causing the mitochondria to aggregate next to the nucleus
prior to recruitment in to AP (Narendra et al. 2010a; Okatsu
et al. 2010).
In addition to recruitment of mitochondria to AP, the
ubiquitination of mitochondrial proteins also prevents
‘primed’ mitochondria from refusing with the ‘healthy’
mitochondrial population by rapidly degrading pro-fusion
proteins including mitofusins via the proteasome (Tanaka
et al. 2010; Gegg and Schapira 2011). The mitochondrial
dysfunction associated with aberrant PINK or parkin func-
tion is likely, at least in part, to increase the accumulation of
damaged mitochondria. Indeed, impairment of oxidative
phosphorylation in PINK1-deﬁcient SH-SY5Y neuroblas-
toma cells was reversed by over-expressing parkin and
restoring autophagic ﬂux (Gegg et al. 2010). However, it
should be noted that constitutive knockdown (KD) of PINK1
expression in SH-SY5Y cells has been reported to activate
mitophagy in the absence of CCCP (Dagda et al. 2009).
In order to maintain mitochondrial function in cells, the
removal of damaged mitochondria by mitophagy needs to be
carefully regulated and counter-balanced by the biogenesis of
mitochondria (Zhu et al. 2013). This is especially critical in
neurons that are very dependent on mitochondrial ATP
synthesis (Van Laar and Berman 2013). Transcription of
PINK1 has been reported to be signiﬁcantly increased 24 h
after induction of mitophagy by CCCP (Gomez-Sanchez
et al. 2014). This is of particular interest as PINK1 has been
linked with mitochondrial biogenesis and the regulation of
mitochondrial DNA levels (Gegg et al. 2009; Tuﬁ et al.
2014). The PGC-1 family of co-activators (PGC-1a, PGC-1b
and PRC) play pivotal roles in cellular metabolism and
mitochondrial biogenesis via their interactions with several
transcription factors such as Nrf1, Nrf2 and cAMP-response
element binding protein (Scarpulla 2011; Zhu et al. 2013).
The biogenesis of lysosomes and transcription of autopha-
gic proteins is also tightly regulated, and a coordinated
lysosomal enhancement and regulation network of genes has
been identiﬁed (Sardiello et al. 2009). Many lysosomal
genes have coordinated lysosomal enhancement and regula-
tion sites in their promoters and are activated by the basic-
loop-helix-loop family of transcription factors such as
transcription factor EB (TFEB) and MITF (Sardiello et al.
2009; Settembre and Ballabio 2014). The activation of TFEB
has been suggested as a treatment for PD, since increased
expression of this transcription factor protects against a-
synuclein and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
mediated dopaminergic cell death (Dehay et al. 2010;
Decressac et al. 2013).
We report that induction of mitophagy in SH-SY5Y cells
results in increased transcription and translation of the
important autophagic protein p62/SQSMT1 and key lysoso-
mal enzymes such as glucocerebrosidase (GCase). The
transcription factors Nrf2 and TFEB were found to translo-
cate to the nucleus upon mitophagy induction, resulting in
transcription of downstream targets. Our results highlight the
integration of the mitochondrial and lysosomal biogenesis
pathways and have important implications for cell home-
ostasis, bioenergetics and protein turnover.
Materials and methods
Cell culture
The human neuroblastoma SH-SY5Y cell line (obtained from
European Collection of Cell Cultures) was cultured in 1:1 (v/v)
Dulbecco’s modiﬁed Eagle’s medium:F12 (Ham) media supple-
mented with 10% fetal bovine serum, 1 mM pyruvate and
penicillin–streptomycin. SH-SY5Y cells with constitutive KD of
PINK1 were generated using HuSH 29mer shRNA constructs (pRS
plasmid; Origene, Rockville, MD, USA) against PINK1
(GCTGTGTATGAAGCCACCATGCCTACATT) or scrambled
negative control shRNA. SH-SY5Y cells were transfected with the
constructs and grown under puromycin selection in media described
above. Human TFEB with a Myc-DDK tag (pCMV6-Entry;
Origene) or PGC-1a with a hemagglutinin tag (pCDNA3.1; kind
gift from Dr Anastasia Kralli, The Scripps Research Institute, USA)
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were transfected in to SH-SY5Y cells and stable expressing clones
selected using G418 (400 lg/mL media). All genetic modiﬁcations
of cells were approved by the University College London.
Transient transfection of SH-SY5Y cells with siRNA
SH-SY5Y cells (1.8 9 105 cells/mL) were transfected with 40 nM
p62 siRNA (sense, CUUCCGAAUCUACAUUAAAtt; antisense,
UUUAAUGUAGAUUCGGAAGat; Ambion, Austin, TX, USA) or
25 nM TFEB siRNA (sense, GCCUGGAGAUGACCAACAATT;
antisense, UUGUUGGUCAUCUCCAGGCGG; Qiagen, Valencia,
CA, USA) or 100 nM Nrf2 siRNA (sense, GAAUGGUCCUA
AAACACCAtt; antisense, UGGUGUUUUAGGACCAUUCtg;
Ambion) or scrambled control siRNA (Ambion) using HiPerfect
transfection reagent (Qiagen). Cells were transfected with siRNA for
3 days.
Citrate synthase activity
Following treatment with 10 lM CCCP, cells were harvested,
washed once with phosphate buffered saline (PBS) and lysed in
0.25% (v/v) Triton X-100 in PBS. Debris was removed by
centrifugation and citrate synthase (CS) activity measured by the
following the oxidation of 5,50-Dithiobis(2-nitrobenzoic acid) in a
spectrophotometer (absorbance at 412 nm) over time at 30°C in the
presence of acetyl co-enzyme A and oxaloacetate (Gegg et al.
2010). Protein concentration in the same aliquot was measured using
the bicinchoninic acid protein assay (Pierce, Rockford, IL, USA)
and enzyme activity expressed as nmol/min/mg protein.
Western blotting
SH-SY5Y cells were harvested with trypsin and lysed on ice in 1%
(v/v) Triton X-100 in PBS supplemented with protease and
phosphatase inhibitors or 0.1% (v/v) sodium dodecyl sulphate
(SDS), 10 mM Tris pH 7.4, 150 mM NaCl supplemented with
DNase and protease/phosphatase inhibitors. Protein lysates (20 lg)
were resolved by sodium dodecyl sulphate–polyacrylamide gel
electrophoresis and transferred to Hybond P (GE Healthcare, Little
Chalfont, UK). Blots were probed with antibodies against Nrf2
(ab31163; Abcam, Cambridge, UK), p62 (610833; BD Biosciences,
Oxford, UK), prohibitin 1 (2426; Cell Signaling Technology,
Beverly, MA, USA), cytochrome oxidase (COX) subunit IV
(ab14744; Abcam), LC3B (2775; Cell Signaling Technology),
cathepsin D (ab6313; Abcam), TOM20 (FL-145; Santa Cruz
Biotechnology, Santa Cruz, CA, USA), TFEB (ab2636; Abcam),
DDK (clone 4C5; Origene), lamin A (ab26300; Abcam), PINK1
(BC100-494; Novus Biologicals, Cambridge, UK), PGC-1a (NBP1-
04676; Novus Biologicals) or b-actin (ab82618; Abcam). Bands
were detected with respective horse radish peroxidase-linked
secondary antibodies (Dako, Carpinteria, CA, USA) and enhanced
chemiluminescence (Pierce). Density of bands was determined using
ImageJ software (NIH, Bethesda, MD, USA) or Image Lab software
5.1 (Bio-Rad Laboratories, Hercules, CA, USA).
Immunofluorescence
Following treatment with CCCP, SH-SY5Y cells on coverslips were
ﬁxed in 3.7% paraformaldehyde. For detection of p62, cells were
permeabilised with glacial methanol, blocked in 2% goat serum in
PBS/0.1% Triton X-100 and incubated with antibodies against p62
(610833; BD Biosciences) and TOM20 (FL-145; Santa Cruz
Biotechnology). For detection of Nrf2 or TFEB, cells were
permeabilised with
PBS/0.1% Triton X-100, blocked with 2% goat serum and 2%
bovine serum albumin in PBS/0.1% Triton X-100, and incubated
with Nrf2 antibody (ab31163; Abcam) or DDK antibody (see above)
overnight at 4°C. Respective ﬂuorescent secondary antibodies (alexa
ﬂuor 488, 594; Invitrogen, Carlsbad, CA, USA) were used for
detection and coverslips mounted in citiﬂuor containing 40,
6-diamidino-2-phenylindole.
Quantitative real-time PCR
Following treatment, RNA was extracted from SH-SY5Y cells using
RNeasy kit (Qiagen). RNA was converted to cDNA (Primer Design,
Southampton, UK) and relative mRNA levels were measured using
SYBERgreen (Applied Biosystems, Paisley, UK). Relative expres-
sion of PGC-1a, NAD(P)H dehydrogenase quinone 1 (NQO1), p62
and PINK1 mRNA was measured with Power SYBRgreen kit
(Applied Biosystems) using a STEP One PCR machine (Applied
Biosystems). b-actin mRNA levels were used to normalise data.
Primers are listed in Table 1. Relative expression was calculated
using the DCT method.
Measurement of glucocerebrosidase and b-hexosaminidase activity
Following treatment, SH-SY5Y cells were lysed in 1% (v/v) Triton
X-100 in PBS and GCase activity determined in samples (20 lg
protein) by hydrolysis of 5 mM 4-methylumbelliferyl-b-D-gluco-
pyranoside in McIIvaine buffer (pH 5.4) in the presence of sodium
taurocholate at 37°C for 1 h (Gegg et al. 2012). The reaction was
stopped by addition of 0.25M glycine (pH 10.4) and 4-methylum-
belliferone ﬂuorescence measured at excitation 360 nm, emission
460 nm.
b-hexosaminidase (HEX) was assayed in above lysates (2 lg
protein) using the ﬂuorogenic substrate 4-methylumbelliferyl-2-
acetoamido-2-deoxy-6-sulfo-b-D-glucopyransoside (2 mM) in
sodium citrate buffer (pH 4.2) at 37°C for 30 min. The reaction
Table 1 Primers for quantitative real-time PCR
Target Sequence Annealing
temperature
(°C)
b-actin 50-TCTACAATGAGCTGCGTGTG-30
50-GGTGAGGATCTTCATGAGGT-30
58
GCase 50-TGCTGCTCTCAACATCCTTGCC-30
50-TAGGTGCGGATGGAGAAGTCAA-30
58
NQO1 50-CAGCTCACCGAGAGCCTAGT-30
50-GAGTGAGCCAGTACGATCAGTG-30
62
p62 50-CAGAGAAGCCCATGGACAG-30
50-AGCTGCCTTGTACCCACATC-30
58
PGC-1a 50-CAGAGAACAGAAACAGCAGCA-30
50-TGGGGTCAGAGGAAGAGATAAA-30
58
PINK1 50-GGACGCTGTTCCTCGTTA-30
50-ATCTGCGATCACCAGCCA-30
58
TFEB 50-CCAGAAGCGAGAGCTCACAGAT-30
50-TGTGATTGTCTTTCTTCTGCCG-30
60
GCase, glucocerebrosidase; NQO1, NAD(P)H dehydrogenase qui-
none 1; TFEB, transcription factor EB.
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was stopped by addition of 0.25M glycine (pH 10.4) and 4-
methylumbelliferone ﬂuorescence measured at excitation 360 nm,
emission 460 nm.
Mitochondrial isolation
SH-SY5Y cells were treated with 10 lM CCCP for 18 h and
cytosolic and mitochondria-enriched fractions prepared as previously
described (Gegg et al. 2010). Equal amounts of protein (20 lg) from
each fraction were measured by western blotting. Given the differing
total volumes of the two fractions (mitochondria 250 lL; cytosol
4000 lL), this equates to approximately 0.5% and 4% of total
cytosolic and mitochondria-enriched fractions respectively. Extrap-
olation from western blot analysis of b-tubulin band density indicates
that the total amount of b-tubulin in the mitochondria-enriched
fraction was 3.5  1.5% (n = 3) of the cytosolic fraction.
Nuclear isolation
For the detection of Nrf2 and PGC-1a, cytosolic and nuclear
fractions were prepared using the EpiQuik Nuclear Extraction Kit II
(Epigentek, Farmingdale, NY, USA). SH-SY5Y cells and PGC-1a
over-expressing cells (~7 9 106 cells) were harvested by trypsin-
isation. For the detection of TFEB, nuclear and cytoplasmic
fractions were prepared from ~2 9 106 cells by scraping in to a
hypotonic buffer (10 mM Hepes (pH 7.9), 10 mM KCl, 0.1 mM
EDTA, 0.1 mM EGTA, 1 mM dithiothreitol, 0.15% NP-40), and
homogenising with 20 strokes of a Dounce homogenizer. An aliquot
(100 lL; 25% total) was reserved for total lysate and was
supplemented with 1% (w/v) SDS and 10 units of DNase (Promega,
Madison, WI, USA). Remainder was centrifuged at 17 000 g for
5 min at 4°C. Supernatant (cytosol) was removed and the nuclear
pellet resuspended in 200 lL high salt buffer (20 mM Hepes,
400 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1 mM dithiothreitol,
0.5% (v/v) NP-40) and solubilised with SDS (1% (w/w) ﬁnal and
10 U DNase (Roczniak-Ferguson et al. 2012). Protein concentra-
tion of each fraction was measured using bicinchoninic acid protein
assay kit.
Statistical analyses
Data are expressed as mean  SEM and statistical signiﬁcance
between groups determined by one-tailed t-test or one-way ANOVA
followed by the Tukey HSD test.
Results
Expression of p62/SQSTM1 increased following CCCP-
induced mitophagy
The autophagic protein p62/SQSTM1 is known to co-localise
with depolarised mitochondria in order to facilitate their
recruitment to AP, which is then degraded by macroau-
tophagy. Treatment of the human neuroblastoma SH-SY5Y
cell line with the mitochondrial uncoupler CCCP (10 lM)
for 18 h resulted in co-localisation of p62 with the
mitochondrial outer membrane protein TOM20 (Fig. 1a).
During this period, p62 protein levels also appeared to
increase in the cytoplasm. Subcellular fractionation also
indicated increased p62 protein in mitochondria-enriched
fractions (Fig. 1b). We also observed a notable increase in
p62 protein expression in the cytosolic fraction after 18 h of
CCCP treatment (Fig. 1b). Analysis of p62 mRNA levels by
quantitative real-time PCR and western blotting for p62
protein levels conﬁrmed that p62 expression was increased
following CCCP treatment (Fig. 1c and d).
To further prove that increased p62 protein levels were
because of de novo expression, rather than inhibition of
macroautophagy/mitophagy, we measured LC3-II protein
levels by western blot, a marker of AP number. LC3-II
protein levels were increased following CCCP treatment
suggesting increased formation of AP (Fig. 2a). Treatment
with baﬁlomycin A1 (Baf A1), which inhibits fusion of AP
with lysosomes, further increased LC3-II levels, indicating
that the increase in AP number following CCCP treatment
was because of increased macroautophagy ﬂux (Fig. 2b).
Furthermore, the mitochondrial content of cells was
decreased following CCCP treatment. The protein levels
of TOM20 (outer membrane) and prohibitin 1 (inner
membrane) were diminished following 18 h of CCCP
treatment (Fig. 2c). These two proteins have been shown by
us and others to be ubiquitinated and degraded following
CCCP-induced PINK1/parkin-mediated mitophagy (Chan
et al. 2011; Sarraf et al. 2013; Gomez-Sanchez et al.
2014).
p62 protein increased following induction of mitophagy but
not starvation-induced macroautophagy
To conﬁrm that increased p62 expression was a response to
PINK1/parkin-mediated mitophagy and not another effect of
CCCP, we investigated p62 expression in SH-SY5Y cells
constitutively expressing either a control scrambled shRNA
plasmid (scram) or shRNA plasmid with a PINK1 target
sequence. PINK1 mRNA levels in two PINK1 KD clonal cell
lines were decreased by 67% and 72% (scram,
0.0050  0.0004 relative mRNA expression; PINK1 118-
3, 0.0011  0.0001 relative mRNA expression; PINK1 118-
4, 0.0017  0.0011 relative mRNA expression). These two
PINK1 KD cell lines did not exhibit accumulation of full-
length PINK1 upon CCCP treatment, unlike scram cells or a
PINK1 KD cell line with only a 45% decrease in PINK1
mRNA levels (117-2; Fig. 3a). Cleaved forms of PINK1
were not detected as FL-PINK1 cannot be imported in to
depolarised mitochondria and therefore is not cleaved by
mitochondrial proteases such as PARL (Jin et al. 2010;
Matsuda et al. 2010). Since full-length PINK1 does not
accumulate on mitochondria, this will inhibit parkin recruit-
ment to mitochondria, and thus mitophagy (Matsuda et al.
2010; Narendra et al. 2010b; Vives-Bauza et al. 2010). This
was reﬂected when we measured the loss of mitochondrial
content in these cells following 24 h CCCP treatment by
assaying the activity of the mitochondrial enzyme CS. CS
activity was decreased by 33% in scram cells treated with
CCCP for 24 h (67.3  4.0% relative to vehicle-treated
cells), while activity was only decreased by 22% in PINK1
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KD cells (77.9  1.8% relative to vehicle-treated cells), and
was signiﬁcantly different compared to scram cells
(p < 0.05; n = 4). CS is a quantitative measurement of
mitochondrial content, and we have previously shown that
loss of CS activity following CCCP treatment can be (a)
increased with over-expression of parkin or (b) impaired by
transient KD of PINK1 with siRNA (Gegg et al. 2010), and
therefore can be used as a measure of mitophagy.
p62 protein levels were increased by 7.3-fold in scram
cells following 18 h of CCCP treatment (Fig. 3b). However,
p62 levels were only increased by 1.9-fold in the PINK1 KD
cells with impaired mitophagy (clone 118-3), and was
signiﬁcantly lower when compared to scram cells treated
with CCCP (p < 0.05). The other PINK1 KD clone (118-4)
resulted in 1.8  0.1-fold induction of p62 protein levels.
When starvation-induced macroautophagy was induced in
SH-SY5Y cells, p62 protein levels were signiﬁcantly
decreased after both 6 and 24 h (Fig 3c). Note that starvation
of SH-SY5Y cells for 24 h had no effect on mitochondrial
content, as measured by CS activity (control,
(a)
(c) (d)
(b)
Fig. 1 p62 protein expression is increased following carbonyl
cyanide m-chlorophenylhydrazone (CCCP) treatment. (a) SH-SY5Y
cells were treated with 10 lM CCCP for 6 or 18 h and p62 (green)
and the mitochondrial protein TOM20 (red) were detected by
immunoﬂuorescence. Nuclei were counter-stained with 40,6-diami-
dino-2-phenylindole (blue) (b) SH-SY5Y cells were treated with
10 lM CCP for 18 h, homogenised and cytosolic and mitochondrial
enriched fractions prepared. Fractions (20 lg protein) were analysed
by western blot for p62 protein. Fractions were also probed for the
mitochondrial protein cytochrome oxidase (COX) subunit IV and the
cytosolic marker b-tubulin. (c) SH-SY5Y cells were treated with
10 lM CCCP and p62 mRNA levels measured by qPCR (n = 7) or
(d) p62 protein levels by western blotting (n = 6). *p < 0.05 versus
0 h; **p < 0.01 versus 0 h.
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498  24 nmol/min/mg protein; starvation, 529  27 nmol/
min/mg protein).
All the above data suggest that induction of p62 expression
in SH-SY5Y cells following CCCP is related to activation of
mitophagy rather than a generic response to induction of
macroautophagy or another effect of CCCP. An explanation
for this p62 induction might be to help maintain the rate of
mitophagy. Similar to reports on other cells like HEK293,
HeLa, cardiomyocytes and mouse embryonic ﬁbroblasts
(MEFs) (Ding et al. 2010; Geisler et al. 2010), the presence
of p62 is required for mitophagy in SH-SY5Y cells. KD of
p62 protein levels by 79% (p < 0.01; Fig. 3d) in SH-SY5Y
cells signiﬁcantly reduced mitophagy (Fig. 3e). CCCP
treatment of SH-SY5Y cells transfected with scrambled
siRNA resulted in a 37% decrease in mitochondrial content
after 18 h (as measured by CS activity). Mitochondrial
content was only decreased by 16% in cells with p62 KD,
and was signiﬁcantly less than cells transfected with
scrambled siRNA (p < 0.05).
Nrf2 and TFEB translocate to nucleus following CCCP
treatment and affects transcription of p62
Two transcription factors that are known to regulate the
expression of p62 are Nrf2 and TFEB (Jain et al. 2010;
Settembre et al. 2012). When SH-SY5Y cells were treated
with CCCP for 18 h the nuclear localisation of Nrf2 was
found to be increased by immunoﬂuorescence (Fig. 4a). A
modest signiﬁcant increase in total Nrf2 protein expression
was observed during this period (116  5% relative to
vehicle-treated SH-SY5Y; p < 0.05; n = 6; Fig. 4b). We
are conﬁdent that this is the correct band for Nrf2 as it is
corresponds to the predicted molecular weight of 68 kDa
and this is diminished by treatment of cells with Nrf2
siRNA (see below). Nuclear and cytosol fractionation of
SH-SY5Y cells treated with CCCP for 18 h supported the
immunoﬂuorescence data (Fig. 4c). Nrf2 localised to the
nucleus was signiﬁcantly increased in cells treated with
CCCP for 18 h, when expressed against the nuclear protein
lamin A (vehicle, 0.82  0.14 Nrf2/lamin A; CCCP,
1.33  0.23; p < 0.05; n = 4). Please note the Nrf2 signal
in the cytosol is much stronger. Therefore, only a small
proportion of the cytosolic fraction (0.6% of total) is
loaded so that the nuclear fraction of Nrf2 is more easily
detected. The increased nuclear location of Nrf2 coincided
with a signiﬁcant increase in the transcription of NQO1
(Fig. 4d), a well described Nrf2 target gene (Kwon et al.
2012; Ichimura et al. 2013). These data all suggest that
Nrf2 does translocate to the nucleus following CCCP
treatment.
To determine whether nuclear translocation of Nrf2 also
affected p62 transcription, we knocked down Nrf2 with
siRNA for 72 h. Quantiﬁcation of western blots for Nrf2
indicated that protein levels were signiﬁcantly decreased by
38% in Nrf2 KD cells (p < 0.05; n = 4), when compared to
scram cells (Fig. 4e). When these cells were treated with
CCCP for 24 h, the induction of p62 mRNA was signiﬁ-
cantly decreased by 35% (p < 0.01; n = 3) when compared
to scram cells treated with CCCP (Fig. 4f).
(a)
(b) (c)
Fig. 2 Macroautophagy ﬂux is increased
and mitochondrial content decreased
following carbonyl cyanide m-
chlorophenylhydrazone (CCCP) treatment.
(a) SH-SY5Y cells were treated with 10 lΜ
CCCPand LC3-II protein levelsmeasured by
western blot. The ratio of (LC3-II/LC3-I)/b-
actin was calculated (n = 4). (b)
Macroautophagy ﬂux was measured by
treating SH-SY5Y cells with vehicle, 10 lΜ
CCCP, or 10 lΜ CCCP + 100 nM
baﬁlomycin A1 for 6 h and LC3-II protein
levels measured by western blotting (n = 4).
Data expressed as (LC3-II/LC3-I)/b-actin. (c)
The decrease in mitochondrial content was
measured bywestern blot after 6, 9 or 18 h of
CCCP treatment usingantibodiesagainst the
mitochondrial proteins TOM20 and prohibitin
1. *p < 0.05 versus 0 h.
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When TFEB protein levels were signiﬁcantly knocked
down in SH-SY5Y cells following 72 h of treatment with
siRNA (Fig. 5a), the increase in p62 mRNA levels were also
signiﬁcantly lower (p < 0.01; n = 4) following 24 h CCCP
treatment, when compared to cells treated with scram siRNA
and CCCP (Fig. 5b). Since we have shown that increased
expression of p62 mRNA following CCCP treatment was
signiﬁcantly impaired following Nrf2 or TFEB KD, we
transiently transfected SH-SY5Y cells with both TFEB and
Nrf2 and measured the effect of CCCP on p62 protein
expression (Fig 5c). Following 24 h of CCCP treatment, p62
protein levels were increased by 2.07  0.21 fold in scram
treated cells (n = 4). In the TFEB and Nrf2 KD cells, p62
protein expression was lower (1.46  0.28; n = 4), although
not signiﬁcantly. This may be explained by the recent report
that homologues of TFEB, MITF and TFE3, are also
activated following PINK1/parkin-mediated mitophagy, and
may contribute to the expression of p62 (Nezich et al. 2015).
Next, we conﬁrmed that TFEB translocated to the nucleus of
SH-SY5Y cells after CCCP treatment. Subcellular fraction-
ation of SH-SY5Y cells treated with CCCP followed by
western blotting of cytosolic and nuclear fractions indicated
that the proportion of endogenous TFEB in the nucleus was
increased (Fig. 5d; SH + vehicle, 0.84  0.01 TFEB/lamin
A; SH + CCCP, 2.38  0.68 TFEB/lamin A; p < 0.01;
n = 5). Nuclear TFEB can also increase its own expression
by a feed-forward mechanism (Sardiello et al. 2009; Set-
tembre et al. 2013). TFEB mRNA levels were signiﬁcantly
increased by 2.11  0.38 fold (p < 0.05; n = 4) following
treatment with CCCP for 18 h (TFEB mRNA levels were
unchanged after 6 or 9 h of CCCP treatment). This was
coincident with a signiﬁcant twofold (p < 0.01; n = 6)
increase in TFEB protein expression after 24 h of CCCP
treatment (Fig. 5e).
Detection of endogenous TFEB by immunoﬂuorescence
was unsuccessful. SH-SY5Y cells expressing recombinant
(a)
(d) (e)
(b) (c)
Fig. 3 Increased p62 expression is prevented in PINK1 knock-down
cells. (a) SH-SY5Y cells expressing scrambled shRNA or PINK1
shRNA (117-2, 118-3, and 118-4) were treated with 10 lM carbonyl
cyanide m-chlorophenylhydrazone (CCCP) for 24 h and full-length
(FL) PINK1 protein levels measured by western blot. No accumulation
of FL PINK1 was observed in 118-3 and 118-4 PINK1 shRNA clones.
(b) SH-SY5Y cells constitutively expressing scrambled (scram) or
PINK1 shRNA (clone 118-3) were treated with vehicle or 10 lM CCCP
for 24 h and p62 protein expression measured by western blotting.
**p < 0.05 versus scram CCCP; n = 9. (c) SH-SY5Y cells were
incubated in serum-free culture media for up to 24 h to induce
starvation-mediated macroautophagy. p62 protein levels were mea-
sured by western blotting. *p < 0.05 versus 0 h; **p < 0.01 versus
0 h; n = 4. (d) SH-SY5Y cells were transfected with scrambled (scram)
or p62 siRNA for 72 h. For the last 24 h, cells were treated with vehicle
(ethanol) or 10 lM CCCP. p62 protein expression was then measured
by western blotting. p62 protein was signiﬁcantly decreased in p62
siRNA cells under basal conditions and following CCCP treatment,
when compared to scram cells. **p < 0.01 versus scram vehicle or
scram CCCP; n = 3. (e) Mitochondrial content was measured in SH-
SY5Y cells treated with scram or p62 siRNA for 72 h by measuring
citrate synthase (CS) activity. For the last 24 h, cells were treated with
vehicle or 10 lM CCCP and data are expressed as % of vehicle.
*p < 0.05 versus scram CCCP treatment; n = 5.
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human TFEB with a DDK tag (TFEB-DDK; Fig. 5f) were
generated, and translocation of TFEB-DDK to the nucleus
was detected 24 h after CCCP treatment (Fig. 5g). Note that
p62 protein levels in TFEB-DDK cells were signiﬁcantly
increased 163% (Fig. 5h), when compared to the parental
SH-SY5Y cell line (SH-SY5Y, 0.347  0.088 p62/b-actin;
TFEB-DDK, 0.568  0.109; p < 0.01; n = 5). These data
suggest that TFEB does translocate to the nucleus following
CCCP treatment and that this has an effect on p62 mRNA
levels.
TFEB increases lysosomal biogenesis following CCCP-
induced mitophagy
In addition to regulating the transcription of p62, TFEB has
been reported to be a master regulator of lysosomal
biogenesis (Sardiello et al. 2009). One of the genes that
TFEB regulates is GBA1, which encodes for the lysosomal
enzyme GCase (EC 3.2.1.45). Mutations in the GBA1 gene
increase the risk of developing PD and loss of GCase activity
has been reported in sporadic PD brains (Sidransky et al.
2009; Gegg et al. 2012). Loss of GCase activity has been
implicated in impairment of the ALP, including mitophagy
(Mazzulli et al. 2011; Sardi et al. 2011; Osellame et al.
2013). Treatment of SH-SY5Y cells with CCCP for 24 h
increased GBA1 mRNA levels 2.45-fold compared to
vehicle-treated cells (SH-SY5Y + vehicle, 100  11.0%;
SH-SY5Y + CCCP, 245.3  74.8%; p = 0.05, n = 4). The
activities of GCase and another TFEB-regulated lysosomal
enzyme HEX (EC 3.2.1.52) were signiﬁcantly increased in
SH-SY5Y cells by 108.8  1.7% (p < 0.01, n = 6) and
(a)
(d) (e) (f)
(b) (c)
Fig. 4 Nrf2 translocates to nucleus and affects p62 expression
following carbonyl cyanide m-chlorophenylhydrazone (CCCP) treat-
ment. (a) SH-SY5Y cells were treated with 10 lM CCCP for 18 h and
Nrf2 nuclear localisation measured by immunoﬂuorescence. Nrf2 is in
green; nuclei in blue (40,6-diamidino-2-phenylindole stain). (b) Nrf2
protein levels measured by western blotting were also increased
following 18 h of CCCP treatment. (c) SH-SY5Y cells were treated with
10 lM CCCP for 18 h and cytosolic and nuclear fractions prepared.
Nrf2 protein was detected in cytosolic (0.6% of total volume) and
nuclear fractions (18% of total volume) by western blotting. The purity
of the nuclear and cytosolic fractions was assessed by western blotting
using lamin A and b-actin antibodies respectively. (d) RNA was
extracted from SH-SY5Y cells treated with CCCP for 0–18 h and
qPCR performed for NQO1 mRNA levels. Data normalised against b-
actin mRNA. **p < 0.01 versus 0 h; n = 3. (e) SH-SY5Y cells were
treated with scram or Nrf2 siRNA for 72 h. Knockdown (KD) of Nrf2
protein levels was measured by western blotting. (f) For the last 24 h,
sister wells were treated with vehicle or 10 lM CCCP. RNA was
extracted and p62 mRNA levels measured by qPCR. Nrf2 knockdown
signiﬁcantly decreased p62 mRNA levels after CCCP treatment. Data
normalised against b-actin mRNA. **p < 0.01 versus scram CCCP;
n = 3.
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123.9  3.6% (p < 0.05, n = 5), respectively, following
24 h of CCCP treatment. The activities of GCase and HEX
were signiﬁcantly increased by 109.7% and 132.2%, respec-
tively, in TFEB-DDK expressing SH-SY5Y cells treated
with CCCP for 24 h (Fig. 6a). Furthermore, the CCCP-
induced increase in GCase activity was not observed in SH-
SY5Y cells with TFEB KD (Fig. 6b).
To determine whether the increase in GCase and HEX
activities were a result of mitophagy induction or another
effect of CCCP, lysosomal activity was measured in scram or
PINK1 KD SH-SY5Y cells. The activities of both GCase and
HEX were signiﬁcantly increased (p < 0.05) in scram SH-
SY5Y cells treated with CCCP by 128.6  6.4% and
130.5  9.3%, respectively, when compared to
(a)
(d)
(g) (h)
(e) (f)
(b) (c)
Fig. 5 TFEB translocates to the nucleus and affects p62 expression
following carbonyl cyanide m-chlorophenylhydrazone (CCCP) treat-
ment. (a) SH-SY5Y cells were treated with scrambled (scram) or TFEB
siRNA for 72 h and TFEB protein expression measured by western
blotting. **p < 0.01 versus scram; n = 4. (b) During the last 24 h of
TFEB knock-down, cells were treated with vehicle or 10 lM CCCP for
24 h and RNA extracted. p62 mRNA levels were measured by qPCR
and normalised to b-actin mRNA levels. **p < 0.01 versus scram
CCCP-treated cells; n = 4. (c) p62 protein levels were also measured
following 24 h CCCP treatment of SH-SY5Y cells treated with scram or
TFEB and Nrf2 siRNA for previous 72 h. (d) Following 24 h CCCP
treatment of SH-SY5Y cells, total cell lysates were prepared and
subcellular fractionation performed to generate cytosolic and nuclear
fractions. TFEBproteinwas detected bywestern blotting. LaminAandb-
actin were also measured to assess purity of the nuclear and cytosolic
fractions respectively. (e) SH-SY5Y cells were treated with CCCP for
24 h and endogenous TFEB measured in total cell lysates by western
blotting. (f) SH-SY5Y cell lines expressing exogenous TFEBwith a DDK
tag (clones T4 and T5) were generated. TFEB protein expression in
parental SH-SY5Y cell line and clones T4 and T5 was measured by
western blotting with a TFEB antibody. Endogenous TFEB is shown by
arrow. (g) TFEB-DDK cells were treated with vehicle or CCCP for 24 h
and TFEB detected by immunoﬂuorescence with an antibody against
DDK (green). Nuclei are stained blue with 40,6-diamidino-2-phenylin-
dole. (h) Total cell lysates were prepared from SH-SY5Y cells (SH) and
TFEB-DDK cells and p62 protein levels measured by western blotting.
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vehicle-treated scram cells (Fig. 6c). CCCP treatment of
PINK1 KD cells did not signiﬁcantly increase either GCase
(112.5  5.0%) or HEX (119.4  7.2%).
Protein expression of the lysosomal protease cathepsin D
(28 kDa mature form; EC 3.4.23.5) was also signiﬁcantly
increased by CCCP treatment in SH-SY5Y cells (Fig. 6d;
SH-SY5Y + vehicle, 0.75  0.08 catD/actin; SH-SY5Y +
CCCP, 0.99  0.10 catD/actin; p < 0.05; n = 6) or TFEB-
DDK-expressing cells (TFEB-DDK + vehicle, 0.55  0.11
catD/actin; TFEB-DDK + CCCP, 0.73  0.13 catD/actin;
p < 0.05; n = 4).
Increased TFEB expression increases mitochondrial content
in SH-SY5Y cells
TFEB has been shown to act in the same pathway as PGC-1a
in the clearance of aggregated huntingtin and lipid
catabolism (Tsunemi et al. 2012; Settembre et al. 2013).
Since PGC-1a plays a role in mitochondrial biogenesis, we
hypothesised that TFEB may also translocate to the nucleus
following mitophagy induction to help stimulate synthesis of
new mitochondria via PGC-1a. First, we investigated
mitochondrial content in SH-SY5Y cells over-expressing
TFEB-DDK (T5 clone). CS activity was signiﬁcantly
increased by 36% (p < 0.01; n = 6) in TFEB-DDK cells
(Fig. 7a). The mitochondrial proteins COXIV and prohibitin
1 were also increased when assessed by western blotting
(Fig. 7b) by 150  33% and 161  36% (p < 0.05 vs. SH-
SY5Y cells; n = 4) respectively. CS activity (137  18%)
and the expression of COXIV (208.1  48.9%) and pro-
hibitin 1 (209.1  23.9%) protein were all increased in
another SH-SY5Y cell line over-expressing TFEB-DDK
(denoted T4; p < 0.05 vs. SH-SY5Y cells; n = 6–7). These
data suggest that cells with increased TFEB expression have
signiﬁcantly more mitochondria.
This increase in mitochondrial content was accompanied
by a signiﬁcant (p < 0.01) increase in PGC-1a mRNA levels
(Fig. 7c). Conversely, TFEB KD in normal SH-SY5Y cells
resulted in a signiﬁcant 33% decrease in PGC-1a mRNA
levels (p < 0.05; Fig. 7d). Endogenous PGC-1a protein is
difﬁcult to detect, with a half-life of <30 min (Olson et al.
2008; Adamovich et al. 2013). We have measured PGC-1a
protein levels in SH-SY5Y and have used a SH-SY5Y cell
line constitutively over-expressing human PGC-1a to vali-
date the antibody (Fig. 7e). A band of the correct size
(110 kDa) was detected in SH-SY5Y cells. However, despite
PGC-1a mRNA levels being increased 71-fold in TFEB-
DDK cells (Fig 7c), only a slight increase in protein
expression was detected (135  20%; n = 8). Even when
PGC-1a mRNA was increased by 442-fold in PGC-1a over-
expressing cells, protein expression was only increased by
267% (Fig. 7e). While an increase in PGC-1a protein levels
was difﬁcult to detect in TFEB-DDK cells, there was
evidence that upon 18 h of CCCP treatment, 2.1  0.4-fold
more PGC-1a was detected in the nucleus, when compared
(a) (b)
(c) (d)
Fig. 6 Lysosomal enzyme activity
increased following carbonyl cyanide m-
chlorophenylhydrazone (CCCP)-induced
mitophagy. (a) TFEB-DDK cells were
treated with vehicle (black) or 10 lM
CCCP (white) for 24 h and the activities of
GCase (nmol/h/mg protein) and b-
hexosaminidase (HEX) (nmol/min/mg
protein) were measured in cell lysates.
*p < 0.05 versus vehicle; **p < 0.01
versus vehicle; n = 4. (b) SH-SY5Y cells
treated with scrambled (scram) or TFEB
siRNA for 72 h. For the last 24 h cells were
treated with vehicle or 10 lM CCCP and
GCase activity measured in cell lysates.
*p < 0.05 versus vehicle; n = 4. (c) SH-
SY5Y cells expressing scrambled (scram)
shRNA or PINK1 shRNA were treated with
vehicle or CCCP for 24 h. GCase and HEX
enzyme activity was measured in cell
lysates. *p < 0.05 versus vehicle; n = 5.
(d) SH-SY5Y cells or TFEB-DDK cells were
treated with vehicle or CCCP for 24 h and
cathepsin D protein levels measured by
western blotting.
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to vehicle treatment (Fig. 7f; n = 3), suggesting PGC-1a is
activated upon mitophagy induction.
Discussion
In this report, we show that there is a signiﬁcant increase in
the synthesis of the autophagic protein p62 via the
transcription factors Nrf2 and TFEB following activation of
PINK1/parkin-mediated mitophagy. TFEB also increased the
expression of lysosomal enzymes such as GCase, HEX and
cathepsin D. Furthermore, TFEB was found to modulate
PGC-1a and increase the mitochondrial content of cells.
Therefore, activation of TFEB following induction of
mitophagy may play a role in the biogenesis of mitochondria
as well as lysosomes (Fig. 8).
The increase in p62 mRNA and protein levels is likely a
cellular response to replace the autophagic protein as it is
degraded with damaged mitochondria. The increase in p62
protein levels was impaired in PINK1-deﬁcient SH-SY5Y
cells supporting the idea that this increase was related to
mitophagy induction. Furthermore, we found that the
expression of p62 was not increased in SH-SY5Y cells
following starvation-induced macroautophagy. A large num-
ber of mitochondrial proteins are ubiquitinated following
CCCP-induced mitophagy (Gegg et al. 2010; Matsuda et al.
2010; Sarraf et al. 2013), some of which are likely to be
(a)
(d) (e) (f)
(b) (c)
Fig. 7 Mitochondrial content and PGC-1a levels are increased in cells
with greater TFEB protein expression. (a) Mitochondrial content was
measured in SH-SY5Y cells and TFEB-DDK cells under basal
conditions by assaying citrate synthase (CS) activity. **p < 0.01
versus SH-SY5Y; n = 6. (b) Western blotting for the mitochondrial
proteins prohibitin 1 and cytochrome oxidase (COX) subunit IV also
indicated that mitochondrial content was increased in TFEB-DDK cells.
(c) PGC-1amRNA levels were measured in SH-SY5Y cells and TFEB-
DDK cells under basal conditions by qPCR. Data normalised against b-
actin mRNA levels. **p < 0.01 versus SH-SY5Y cells; n = 3. (d) SH-
SY5Y cells were treated with scrambled (scram) or TFEB siRNA for
72 h and PGC-1a mRNA levels measured. *p < 0.05 versus scram;
n = 4. (e) PGC-1a protein levels were detected by western blotting in
total cell lysates of SH-SY5Y cells, TFEB-DDK cells and a SH-SY5Y
cell line over-expressing human PGC-1a. The fold increase in PGC-1a
protein density for this blot and PGC-1a mRNA levels of the respective
cell lines are reported underneath the blot. (f) TFEB-DDK cells were
treated with 10 lM carbonyl cyanide m-chlorophenylhydrazone
(CCCP) for 18 h and cytosolic and nuclear fractions prepared. PGC-
1a protein was detected in cytosolic (3.5% of total volume) and nuclear
fractions (35% of total volume) by western blotting. The purity of the
nuclear and cytosolic fractions was assessed by western blotting using
lamin A and b-actin antibodies respectively.
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bound by p62/LC3 to aid in the recruitment of mitochondria
to APs and localisation to perinuclear clusters (Narendra
et al. 2010a; Okatsu et al. 2010). Similar to previous reports,
we found that p62 was necessary for mitophagy to occur
(Ding et al. 2010; Geisler et al. 2010). An increase in p62
protein levels has also been found in HeLa cells (Sarraf et al.
2013) and MEFs (Ichimura et al. 2013) following treatment
with depolarising agents CCCP and valinomycin respec-
tively. An increase in autophagy proteins ATG5, ATG12 and
LC3B has also been noted in HUVECs following induction
of mitophagy by DNA damage, although the authors did not
investigate p62 (Mai et al. 2012). During the submission
process of this paper, TFEB and two other homologues
(MITF and TFE3) from the same transcription factor family
were reported to be activated in HeLa cells following
mitophagy induction in a PINK1- and parkin-dependent
manner (Nezich et al. 2015). The co-activation of MITF and
TFE3 most likely explains why the KD of Nrf2 and TFEB
(either on their own or in combination) did not completely
abolish the increase in p62 mRNA and protein levels
following mitophagy induction.
While the increase in p62 might be because of a general
up-regulation of the ALP, it cannot be discounted that the
elevation of p62 is for another purpose. In addition to its role
in autophagy, p62 has been shown to regulate the oxidative
stress response and mitochondrial biogenesis via Nrf2 (Jain
et al. 2010; Kwon et al. 2012; Ichimura et al. 2013). Under
basal conditions, Nrf2 is constitutively degraded by the
ubiquitin–proteasome system via its association with
KEAP1, an adaptor for a cullin-ring ubiquitin ligase com-
plex. Upon oxidative stress, this complex dissociates allow-
ing Nrf2 to translocate to the nucleus and induce transcription
of genes with an antioxidant response element, including
NQO1 and p62. It is of interest that Nrf2 and p62 exist in a
positive feedback loop; p62 disrupts the Nrf2-KEAP1
complex by direct interaction resulting in stabilisation of
Nrf2 (Jain et al. 2010; Ichimura et al. 2013). Therefore, the
activation of Nrf2 we observe after CCCP treatment may in
part be mediated via p62, increasing mitochondrial biogen-
esis and antioxidant defences (Fig. 8). Intriguingly, p62
knockout MEFs exhibit increased oxidative stress, fragmen-
tation of mitochondria, and decreased mtDNA levels (Okatsu
et al. 2010; Kwon et al. 2012; Seibenhener et al. 2013).
Whether these observations are a result of impaired antiox-
idant response and/or mitophagy remains unclear.
TFEB coordinates the expression of lysosomal and
autophagic proteins following starvation-induced macroau-
tophagy (Settembre et al. 2012). We report that the induction
of mitophagy also increased the nuclear localisation of TFEB
and expression of TFEB target genes such as GBA1 and
HEXB following mitophagy induction. We hypothesise that
this is required to ensure prolonged activation of the ALP
during mitophagy. GCase activity was only increased by
approximately 10% after 24 h of CCCP treatment. Longer
CCCP treatment results in cell death (after 30 h), so it is
unknown if GCase activity was increased further at later time
points. Since the half-life of GCase has been estimated to be
about 30 h (Witte et al. 2010), and is thus relatively long
lived, perhaps induction does not need to be so great. Indeed
the induction of HEXB mRNA levels was reported to be
greater than GBA mRNA levels in HeLa cells over-
expressing TFEB (Sardiello et al. 2009).
It is becoming increasingly evident that the functions of
TFEB and PGC-1a are interconnected (Tsunemi et al. 2012;
Settembre et al. 2013). The KD of TFEB has been shown to
prevent the PGC-1a-mediated reversal of huntingtin aggre-
gation (Tsunemi et al. 2012). The authors showed that
PGC-1a bound to a TFEB-luciferase reporter construct
Fig. 8 Activation of Nrf2 and TFEB following mitophagy induction.
Stimulation of PINK1-dependent mitophagy results in the nuclear
translocation of the transcription factors Nrf2 and TFEB. Both transcrip-
tion factors increase the expression of the autophagic protein p62. Nrf2 is
involved in theantioxidant responseandmitochondrial biogenesis. TFEB
also increases lysosomal biogenesis and can affect mitochondrial
biogenesis by increasing expression of PGC-1a. Activation of Nrf2 and
TFEB following damage to mitochondria and induction of mitophagy will
likely coordinate protection from oxidative stress (via antioxidant
response element), replace damaged mitochondria removed by mito-
phagy, andmaintain efﬁcient macroautophagy by stimulating expression
of autophagic proteins suchas p62and synthesis of lysosomal enzymes.
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suggesting PGC-1a was upstream of TFEB. Conversely, the
TFEB-regulation of lipid metabolism in the liver was
mediated via the transcription of several genes, including
PGC-1a (Settembre et al. 2013). Therefore, activation of
TFEB might also contribute to the increased mitochondrial
biogenesis observed after PINK1/parkin-mediated mito-
phagy. The expression of two mitochondrial proteins (pro-
hibitin 1 and COXIV) was signiﬁcantly increased in SH-
SY5Y cell lines expressing exogenous TFEB. This was
coincident with a signiﬁcant increase in the expression of
PGC-1a mRNA. Induction of mitophagy with CCCP in
TFEB-DDK cells also increased the nuclear localisation of
PGC-1a. A coordinated up-regulation of TFEB and PGC-1a
has recently been reported in a knock-out model of GCN5L1,
a component of the mitochondrial deacetylase machinery
(Scott et al. 2014). KD of GCN5L1 in liver cells increased
the co-localisation of mitochondria with LC3, p62 and
ubiquitin in a parkin-independent manner (Webster et al.
2013). However, analysis in GCN5L1 knock-out MEFs
indicated that while TFEB-mediated autophagy was acti-
vated, there was no loss of mitochondrial content since the
expression of PGC-1a was also increased, thus balancing
mitophagy with biogenesis (Scott et al. 2014).
The pathway(s) by which TFEB and PGC-1a are activated
and how they are coordinated remains to be elucidated. CCCP
treatment has previously been shown to increase the
transcription of PINK1 in a calcium-dependent manner by
an unknown transcription factor (Gomez-Sanchez et al.
2014). CCCP treatment dysregulates calcium homeostasis in
SH-SY5Y cells and thus may induce PGC-1a via the calcium-
sensitive cAMP response element binding protein (Zhu et al.
2013; Gomez-Sanchez et al. 2014). However, the increased
expression of p62 and lysosomal proteins was diminished in
PINK1-deﬁcient cells despite the presence of CCCP, sug-
gesting that transcription factor activation is a mitophagy-
speciﬁc response, rather than a generalised increased in
cellular calcium. Further work is required to determine how
TFEB is activated. TFEB can be phosphorylated by kinases
such as mTORC1 and protein kinase Cb (Martina et al. 2012;
Roczniak-Ferguson et al. 2012; Settembre et al. 2012; Fer-
ron et al. 2013), with phosphorylation of serines being
implicated in both preventing nuclear translocation of TFEB
(Martina et al. 2012; Roczniak-Ferguson et al. 2012) and
being required for the biological functions of TFEB (Pe~na-
Llopis et al. 2011; Ferron et al. 2013). Since PINK1 is a
serine/threonine kinase, it is a putative candidate for directly
phosphorylating TFEB or initiating a kinase cascade to
activate TFEB. Nezich et al. 2015 were also unable to exactly
identify how nuclear translocation of TFEB is achieved
following induction of PINK1/parkin-mediated mitophagy in
HeLa, but did rule out the possible involvement of 50 AMP-
activated protein kinase, which can inhibit mTORC1 (Lamb
et al. 2013). However, data suggested that parkin, presum-
ably following phosphorylation by PINK1, inactivated Rag
GTPases (Nezich et al. 2015). Inactivation of Rag GTPases
has been shown to cause mTORC1 to dissociate from TFEB,
thus decreasing the phosphorylation of TFEB and allowing
translocation to the nucleus (Settembre et al. 2012).
There is increasing interest in TFEB and neurodegenera-
tive disorders associated with impaired proteostasis. In
addition to the link between TFEB and huntingtin (Tsunemi
et al. 2012), TFEB-mediated autophagy has been reported to
protect against a-synuclein-induced dopaminergic neuronal
loss (Decressac et al. 2013). The expression of lysosomal
proteins such as LAMP2A and GCase are decreased in the
brains of sporadic PD brains (Alvarez-Erviti et al. 2010;
Dehay et al. 2010; Gegg et al. 2012). These deﬁciencies
very likely contribute to the impairment of the ALP and thus
the protein aggregation and mitochondrial dysfunction
associated with PD (Terman et al. 2010; Nixon 2013). Our
study suggests that the activation of TFEB might not only be
a strategy to improve lysosomal function, and hence
autophagy, but would also be useful in promoting the
synthesis of functional mitochondria.
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